Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer
NCT03971045
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Chest Wall Tumor
Interventions
DRUG:
Pembrolizumab
Sponsor
European Institute of Oncology